Unicycive Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • Unicycive Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $20K, a 66.7% increase year-over-year.
  • Unicycive Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $90K.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2023 was $82K, a 1267% increase from 2022.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2022 was $6K, a 99% decline from 2021.
  • Unicycive Therapeutics, Inc. annual Interest Expense for 2021 was $628K, a 157% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $90K $20K +$8K +66.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $82K $20K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $18K +$15K +500% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $32K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $12K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $3K -$52K -94.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q4 2021 $628K $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $55K -$21K -27.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $321K +$319K +15950% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $252K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $76K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.